Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 3, 2004, Pages 478-480

  Levecque, C ^a   Elbaz, A ^b   Clavel, J ^c   Vidal, J S ^d   Amouyel, P ^a   Alperovitch A ^b   Tzourio, C ^b   Chartier Harlin, M C ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; HAPLOTYPE; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; SAITOHIN GENE; TAU GENE;

EID: 1542721757     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.015750     Document Type: Article

References (23)

1. Verpillat P, Camuzat A, Hannequin D, et al. Association between the extended tau haplotype and frontotemporal dementia. Arch Neurol 2002;59:935-9.
2. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711-15.
3. Conrad C, Andreadis A, Trojanowski JQ, et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997;41:277-81.
4. Poorkaj P, Muma NA, Zhukareva V, et al. An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann Neurol 2002;52:511-16.
5. Pastor P, Ezquerra M, Munoz E, et al. Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann Neurol 2000;47:242-5.
6. Golbe LI, Lazzarini AM, Spychala JR, et al. The tau A0 allele in Parkinson's disease. Mov Disord 2001;16:442-7.
7. Hoenicka J, Perez M, Perez-Tur J, et al. The tau gene A0 allele and progressive supranuclear palsy. Neurology 1999;53:1219-25.
8. Maraganore DM, Hernandez DG, Singleton AB, et al. Case-control study of the extended tau gene haplotype in Parkinson's disease. Ann Neurol 2001;50:658-61.
9. Martin ER, Scott WK, Nance AM, et al. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA 2001;286:2245-50.
10. Fairer M, Skipper L, Berg M, et al. The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population. Neurosci Lett 2002;322:83-6.
11. Conrad C, Vianna C, Freeman M, et al. A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease. Proc Natl Acad Sci USA 2002;99:7751-6.
12. Elbaz A, Levecque C, Clavel J, et al. S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship. Mov Disord 2003;18:130-7.
13. Levecque C, Elbaz A, Clavel J, et al. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum Mol Genet 2003;12:79-86.
14. de Rijk MC, Rocca WA, Anderson DW, et al. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997;48:1277-81.
15. Elbaz A, Grigoletto F, Baldereschi M, et al. Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology 1999;52:1876-82.
16. Payami H, Zareparsi S, James D, et al. Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol 2002;59:848-50.
17. Scott WK, Nance MA, Watts RL, et al. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 2001;286:2239-44.
18. Varani L, Hasegawa M, Spillantini MG, et al. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci USA 1999;96:8229-34.
19. Grover A, Houlden H, Baker M, et al. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 1999;274:15134-43.
20. D'Souza I, Schellenberg GD. Tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5′ and 3′ splice sites. J Biol Chem 2002;277(29):26587-99.
21. Jensen PH, Hager H, Nielsen MS, et al. Alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J Biol Chem 1999;274:25481-9.
22. Wittmann CW, Wszolek MF, Shulman JM, et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001;293:711-14.
23. Andreadis A, Brown WM, Kosik KS. Structure and novel exons of the human tau gene. Biochemistry 1992;31:10626-33.